Viking Therapeutics
VKTX
#3911
Rank
ยฃ2.41 B
Marketcap
ยฃ18.93
Share price
-4.14%
Change (1 day)
-27.63%
Change (1 year)

EPS for Viking Therapeutics (VKTX)

EPS in 2026 (TTM): -ยฃ4.06

According to Viking Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ4.13. In 2025 the company made an earnings per share (EPS) of -ยฃ2.43 a decrease over its 2024 EPS that were of -ยฃ0.76.

EPS history for Viking Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ4.0666.93%
2025-ยฃ2.43218%
2024-ยฃ0.76
2022-ยฃ0.7026.39%
2021-ยฃ0.5533.33%
2020-ยฃ0.41
2018-ยฃ0.30-51.25%
2017-ยฃ0.61-20%
2016-ยฃ0.76-64.08%
2015-ยฃ2.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
-ยฃ3.97-3.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-ยฃ0.15-96.30%๐Ÿ‡บ๐Ÿ‡ธ USA